Maria Schuller De Almeida
Concepts (269)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bone and Bones | 25 | 2025 | 494 | 3.480 |
Why?
| | Osteoblasts | 29 | 2025 | 475 | 3.260 |
Why?
| | Osteoclasts | 22 | 2024 | 428 | 2.570 |
Why?
| | Forkhead Transcription Factors | 11 | 2019 | 121 | 2.020 |
Why?
| | Aging | 16 | 2021 | 708 | 1.820 |
Why?
| | Osteoporosis | 9 | 2025 | 162 | 1.630 |
Why?
| | Cell Differentiation | 14 | 2024 | 674 | 1.560 |
Why?
| | Osteogenesis | 14 | 2023 | 366 | 1.540 |
Why?
| | Mitochondria | 6 | 2025 | 428 | 1.530 |
Why?
| | Osteocytes | 10 | 2024 | 226 | 1.510 |
Why?
| | Estrogens | 12 | 2023 | 223 | 1.450 |
Why?
| | Mice | 48 | 2025 | 5965 | 1.260 |
Why?
| | Bone Resorption | 8 | 2022 | 302 | 1.210 |
Why?
| | Bone Density | 15 | 2025 | 399 | 1.200 |
Why?
| | Animals | 57 | 2025 | 13523 | 1.120 |
Why?
| | Estrogen Receptor alpha | 7 | 2016 | 85 | 1.040 |
Why?
| | Estradiol | 5 | 2024 | 215 | 1.030 |
Why?
| | Oxidative Stress | 12 | 2013 | 810 | 0.960 |
Why?
| | Wnt Proteins | 9 | 2016 | 102 | 0.950 |
Why?
| | Glucocorticoids | 6 | 2015 | 235 | 0.840 |
Why?
| | Stem Cells | 7 | 2016 | 182 | 0.840 |
Why?
| | RANK Ligand | 6 | 2024 | 187 | 0.820 |
Why?
| | Apoptosis | 13 | 2024 | 1127 | 0.800 |
Why?
| | Tumor Suppressor Protein p53 | 2 | 2024 | 224 | 0.790 |
Why?
| | Signal Transduction | 14 | 2020 | 1716 | 0.770 |
Why?
| | Mice, Inbred C57BL | 22 | 2024 | 1903 | 0.770 |
Why?
| | Reactive Oxygen Species | 8 | 2025 | 425 | 0.770 |
Why?
| | Androgens | 4 | 2017 | 70 | 0.680 |
Why?
| | beta Catenin | 5 | 2014 | 103 | 0.640 |
Why?
| | Bone Diseases, Metabolic | 2 | 2022 | 78 | 0.600 |
Why?
| | Bone Remodeling | 5 | 2020 | 154 | 0.540 |
Why?
| | Adaptor Proteins, Signal Transducing | 4 | 2023 | 205 | 0.540 |
Why?
| | NAD | 3 | 2025 | 45 | 0.540 |
Why?
| | Gene Deletion | 6 | 2020 | 276 | 0.530 |
Why?
| | Wnt Signaling Pathway | 4 | 2018 | 95 | 0.500 |
Why?
| | Mice, Knockout | 9 | 2025 | 909 | 0.500 |
Why?
| | Receptors, Androgen | 3 | 2015 | 47 | 0.480 |
Why?
| | Transcription, Genetic | 9 | 2015 | 385 | 0.470 |
Why?
| | Adenosine Triphosphate | 4 | 2024 | 208 | 0.470 |
Why?
| | Sirtuin 1 | 2 | 2015 | 29 | 0.470 |
Why?
| | Models, Animal | 3 | 2020 | 228 | 0.450 |
Why?
| | Adipogenesis | 3 | 2020 | 49 | 0.450 |
Why?
| | Periosteum | 1 | 2024 | 26 | 0.430 |
Why?
| | Porosity | 3 | 2017 | 31 | 0.410 |
Why?
| | Prednisolone | 3 | 2011 | 56 | 0.400 |
Why?
| | Chemokine CXCL12 | 2 | 2020 | 34 | 0.390 |
Why?
| | Matrix Metalloproteinase 13 | 1 | 2022 | 10 | 0.390 |
Why?
| | Oxidative Phosphorylation | 2 | 2024 | 46 | 0.380 |
Why?
| | Gonadal Steroid Hormones | 3 | 2016 | 39 | 0.380 |
Why?
| | Female | 31 | 2025 | 28105 | 0.370 |
Why?
| | Ovariectomy | 7 | 2022 | 113 | 0.370 |
Why?
| | Sirtuin 3 | 1 | 2021 | 18 | 0.360 |
Why?
| | Femur | 6 | 2016 | 133 | 0.350 |
Why?
| | Protein Isoforms | 1 | 2011 | 126 | 0.350 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 5 | 2010 | 83 | 0.350 |
Why?
| | Autophagy | 4 | 2019 | 197 | 0.340 |
Why?
| | Mice, Transgenic | 8 | 2020 | 563 | 0.330 |
Why?
| | Cell Lineage | 5 | 2018 | 89 | 0.320 |
Why?
| | Parathyroid Hormone | 2 | 2010 | 149 | 0.310 |
Why?
| | Sirtuins | 1 | 2019 | 12 | 0.310 |
Why?
| | Shc Signaling Adaptor Proteins | 4 | 2011 | 19 | 0.310 |
Why?
| | Cells, Cultured | 10 | 2020 | 1589 | 0.290 |
Why?
| | Phosphoproteins | 1 | 2018 | 121 | 0.270 |
Why?
| | X-Ray Microtomography | 5 | 2016 | 79 | 0.270 |
Why?
| | Macrophages | 3 | 2024 | 378 | 0.260 |
Why?
| | Gene Expression Regulation | 4 | 2020 | 1006 | 0.260 |
Why?
| | Cell Line | 8 | 2020 | 1045 | 0.250 |
Why?
| | Gene Expression Regulation, Enzymologic | 3 | 2014 | 181 | 0.250 |
Why?
| | Osteoprotegerin | 2 | 2016 | 53 | 0.250 |
Why?
| | Homeodomain Proteins | 3 | 2022 | 81 | 0.240 |
Why?
| | Apolipoproteins E | 1 | 2016 | 57 | 0.240 |
Why?
| | Hydrogen Peroxide | 4 | 2016 | 120 | 0.240 |
Why?
| | Male | 20 | 2022 | 26696 | 0.240 |
Why?
| | Atherosclerosis | 2 | 2016 | 224 | 0.240 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2016 | 137 | 0.240 |
Why?
| | Biomedical Research | 1 | 2018 | 256 | 0.240 |
Why?
| | NF-kappa B | 3 | 2017 | 328 | 0.230 |
Why?
| | Aorta | 1 | 2016 | 169 | 0.230 |
Why?
| | RNA | 2 | 2023 | 172 | 0.230 |
Why?
| | Lipid Metabolism | 3 | 2013 | 188 | 0.230 |
Why?
| | Enzyme Activation | 6 | 2015 | 272 | 0.220 |
Why?
| | Phosphatidylinositol 3-Kinases | 2 | 2005 | 150 | 0.220 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2016 | 397 | 0.220 |
Why?
| | Bone Development | 1 | 2014 | 66 | 0.220 |
Why?
| | Organ Size | 4 | 2018 | 231 | 0.220 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2016 | 220 | 0.210 |
Why?
| | Cell Count | 4 | 2020 | 144 | 0.210 |
Why?
| | Integrases | 3 | 2018 | 44 | 0.200 |
Why?
| | Aniline Compounds | 2 | 2020 | 46 | 0.200 |
Why?
| | Stress, Mechanical | 2 | 2019 | 95 | 0.190 |
Why?
| | Homeostasis | 3 | 2023 | 206 | 0.190 |
Why?
| | Proto-Oncogene Proteins c-akt | 3 | 2011 | 172 | 0.190 |
Why?
| | Chondrocytes | 2 | 2024 | 41 | 0.190 |
Why?
| | Sulfonamides | 2 | 2020 | 133 | 0.190 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2016 | 583 | 0.180 |
Why?
| | B-Lymphocytes | 1 | 2012 | 185 | 0.180 |
Why?
| | Humans | 21 | 2023 | 52336 | 0.180 |
Why?
| | Phosphorylation | 6 | 2010 | 531 | 0.180 |
Why?
| | TCF Transcription Factors | 2 | 2007 | 11 | 0.170 |
Why?
| | Energy Metabolism | 1 | 2023 | 306 | 0.170 |
Why?
| | Glucose | 2 | 2016 | 357 | 0.170 |
Why?
| | Monocyte-Macrophage Precursor Cells | 1 | 2020 | 7 | 0.170 |
Why?
| | Blotting, Western | 5 | 2016 | 596 | 0.170 |
Why?
| | Estrenes | 3 | 2006 | 11 | 0.170 |
Why?
| | Protein Kinase C | 1 | 2010 | 70 | 0.170 |
Why?
| | Oxidation-Reduction | 3 | 2023 | 328 | 0.170 |
Why?
| | Models, Biological | 5 | 2015 | 743 | 0.160 |
Why?
| | Water | 1 | 2009 | 82 | 0.160 |
Why?
| | Dexamethasone | 1 | 2011 | 440 | 0.160 |
Why?
| | Neovascularization, Physiologic | 1 | 2009 | 86 | 0.160 |
Why?
| | Ion Channels | 1 | 2019 | 70 | 0.160 |
Why?
| | Cell Cycle Proteins | 3 | 2018 | 173 | 0.150 |
Why?
| | PPAR gamma | 1 | 2009 | 73 | 0.150 |
Why?
| | Transcription Factors | 3 | 2013 | 574 | 0.150 |
Why?
| | Arachidonate 12-Lipoxygenase | 3 | 2016 | 13 | 0.150 |
Why?
| | Arachidonate 15-Lipoxygenase | 3 | 2016 | 13 | 0.150 |
Why?
| | Cell Proliferation | 4 | 2014 | 1029 | 0.150 |
Why?
| | Blood Platelets | 1 | 2020 | 256 | 0.140 |
Why?
| | Antineoplastic Agents | 1 | 2025 | 1222 | 0.130 |
Why?
| | Bone Diseases | 1 | 2007 | 95 | 0.130 |
Why?
| | Receptors, Estrogen | 1 | 2006 | 132 | 0.130 |
Why?
| | Cell Nucleus | 2 | 2013 | 191 | 0.120 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2005 | 34 | 0.120 |
Why?
| | Superoxide Dismutase | 1 | 2025 | 120 | 0.120 |
Why?
| | Receptors, Calcitriol | 1 | 2005 | 21 | 0.120 |
Why?
| | Calcitriol | 1 | 2005 | 39 | 0.120 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2005 | 72 | 0.120 |
Why?
| | src-Family Kinases | 1 | 2005 | 34 | 0.120 |
Why?
| | Heterocyclic Compounds, 2-Ring | 1 | 2014 | 2 | 0.110 |
Why?
| | Catalase | 1 | 2014 | 74 | 0.110 |
Why?
| | Single-Cell Analysis | 1 | 2024 | 73 | 0.110 |
Why?
| | Lumbar Vertebrae | 1 | 2013 | 103 | 0.100 |
Why?
| | Bone Marrow Cells | 2 | 2015 | 190 | 0.100 |
Why?
| | Phenotype | 2 | 2015 | 799 | 0.090 |
Why?
| | Up-Regulation | 3 | 2010 | 462 | 0.090 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2011 | 106 | 0.090 |
Why?
| | DNA-Binding Proteins | 1 | 2003 | 429 | 0.080 |
Why?
| | Spine | 2 | 2016 | 88 | 0.080 |
Why?
| | Gene Knock-In Techniques | 2 | 2010 | 22 | 0.080 |
Why?
| | Alleles | 2 | 2012 | 277 | 0.080 |
Why?
| | Protein Processing, Post-Translational | 1 | 2011 | 158 | 0.080 |
Why?
| | Multienzyme Complexes | 2 | 2010 | 44 | 0.080 |
Why?
| | DNA Primers | 2 | 2014 | 209 | 0.080 |
Why?
| | HeLa Cells | 3 | 2005 | 263 | 0.080 |
Why?
| | MAP Kinase Kinase 4 | 2 | 2011 | 30 | 0.080 |
Why?
| | Insulin | 1 | 2011 | 481 | 0.080 |
Why?
| | Primary Cell Culture | 2 | 2020 | 62 | 0.080 |
Why?
| | Telomere | 1 | 2018 | 38 | 0.070 |
Why?
| | Bone Morphogenetic Protein 2 | 2 | 2010 | 48 | 0.070 |
Why?
| | Haploinsufficiency | 1 | 2018 | 16 | 0.070 |
Why?
| | Core Binding Factor Alpha 1 Subunit | 1 | 2018 | 46 | 0.070 |
Why?
| | Genomic Instability | 1 | 2018 | 89 | 0.070 |
Why?
| | HEK293 Cells | 1 | 2018 | 232 | 0.070 |
Why?
| | Age Factors | 1 | 2020 | 1127 | 0.070 |
Why?
| | Trans-Activators | 1 | 2018 | 138 | 0.070 |
Why?
| | Mice, Inbred BALB C | 1 | 2017 | 312 | 0.070 |
Why?
| | Myeloid Cells | 1 | 2016 | 39 | 0.070 |
Why?
| | Calcification, Physiologic | 1 | 2016 | 42 | 0.070 |
Why?
| | Immunomagnetic Separation | 1 | 2016 | 8 | 0.060 |
Why?
| | Cell Survival | 2 | 2009 | 602 | 0.060 |
Why?
| | Heme Oxygenase-1 | 1 | 2015 | 18 | 0.060 |
Why?
| | Orchiectomy | 1 | 2015 | 38 | 0.060 |
Why?
| | Absorptiometry, Photon | 1 | 2016 | 162 | 0.060 |
Why?
| | Quercetin | 1 | 2025 | 18 | 0.060 |
Why?
| | Piperidones | 1 | 2025 | 7 | 0.060 |
Why?
| | Acetylation | 1 | 2015 | 96 | 0.060 |
Why?
| | Monocytes | 1 | 2016 | 130 | 0.060 |
Why?
| | Interleukin-1beta | 1 | 2016 | 86 | 0.060 |
Why?
| | Genes, Reporter | 2 | 2017 | 88 | 0.060 |
Why?
| | Dioxolanes | 1 | 2025 | 15 | 0.060 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2015 | 155 | 0.060 |
Why?
| | Immunoblotting | 1 | 2015 | 119 | 0.060 |
Why?
| | Epigenesis, Genetic | 1 | 2018 | 407 | 0.060 |
Why?
| | Cyclophosphamide | 1 | 2025 | 171 | 0.060 |
Why?
| | Interleukin-6 | 1 | 2016 | 278 | 0.060 |
Why?
| | Lipoproteins, LDL | 1 | 2016 | 169 | 0.060 |
Why?
| | Flow Cytometry | 1 | 2016 | 404 | 0.060 |
Why?
| | Nuclear Receptor Co-Repressor 1 | 1 | 2023 | 4 | 0.050 |
Why?
| | Proto-Oncogene Proteins | 2 | 2005 | 151 | 0.050 |
Why?
| | Co-Repressor Proteins | 1 | 2023 | 19 | 0.050 |
Why?
| | Transfection | 2 | 2005 | 372 | 0.050 |
Why?
| | Diet, High-Fat | 1 | 2016 | 237 | 0.050 |
Why?
| | Ligands | 2 | 2005 | 207 | 0.050 |
Why?
| | Growth Substances | 1 | 2013 | 22 | 0.050 |
Why?
| | Mice, 129 Strain | 1 | 2013 | 38 | 0.050 |
Why?
| | Protein Structure, Tertiary | 2 | 2005 | 252 | 0.050 |
Why?
| | Doxorubicin | 1 | 2025 | 239 | 0.050 |
Why?
| | Gene Knockout Techniques | 1 | 2013 | 46 | 0.050 |
Why?
| | Antioxidants | 2 | 2010 | 258 | 0.050 |
Why?
| | TNF Receptor-Associated Factor 6 | 1 | 2023 | 8 | 0.050 |
Why?
| | Base Sequence | 1 | 2014 | 648 | 0.050 |
Why?
| | Hematopoiesis | 1 | 2022 | 70 | 0.050 |
Why?
| | Adiposity | 1 | 2013 | 143 | 0.050 |
Why?
| | Mutation | 1 | 2017 | 1351 | 0.050 |
Why?
| | TNF-Related Apoptosis-Inducing Ligand | 1 | 2011 | 20 | 0.050 |
Why?
| | Inflammation | 1 | 2016 | 642 | 0.050 |
Why?
| | Bone Marrow | 1 | 2013 | 364 | 0.050 |
Why?
| | Disease Models, Animal | 1 | 2016 | 1484 | 0.040 |
Why?
| | Gene Expression | 1 | 2023 | 623 | 0.040 |
Why?
| | Oxidants | 1 | 2010 | 51 | 0.040 |
Why?
| | Smad1 Protein | 1 | 2010 | 5 | 0.040 |
Why?
| | Glutathione Reductase | 1 | 2010 | 14 | 0.040 |
Why?
| | Chimera | 1 | 2010 | 10 | 0.040 |
Why?
| | Cytokines | 1 | 2023 | 625 | 0.040 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2009 | 12 | 0.040 |
Why?
| | Transgenes | 1 | 2010 | 54 | 0.040 |
Why?
| | T-Lymphocytes | 1 | 2012 | 340 | 0.040 |
Why?
| | Gene Targeting | 1 | 2010 | 30 | 0.040 |
Why?
| | bcl-X Protein | 1 | 2020 | 54 | 0.040 |
Why?
| | Organ Specificity | 1 | 2010 | 117 | 0.040 |
Why?
| | Proteolysis | 1 | 2020 | 102 | 0.040 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2009 | 62 | 0.040 |
Why?
| | Gene Knockdown Techniques | 1 | 2019 | 110 | 0.040 |
Why?
| | Aldehydes | 1 | 2009 | 81 | 0.040 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2009 | 186 | 0.040 |
Why?
| | Cattle | 1 | 2009 | 207 | 0.040 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2020 | 140 | 0.040 |
Why?
| | GATA4 Transcription Factor | 1 | 2017 | 11 | 0.030 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2022 | 606 | 0.030 |
Why?
| | G1 Phase Cell Cycle Checkpoints | 1 | 2017 | 17 | 0.030 |
Why?
| | Luminescent Proteins | 1 | 2017 | 51 | 0.030 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2017 | 68 | 0.030 |
Why?
| | Dihydrotestosterone | 1 | 2006 | 14 | 0.030 |
Why?
| | Smad Proteins | 1 | 2006 | 16 | 0.030 |
Why?
| | Response Elements | 1 | 2006 | 29 | 0.030 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2006 | 67 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2010 | 1142 | 0.030 |
Why?
| | Wnt2 Protein | 1 | 2005 | 2 | 0.030 |
Why?
| | Frizzled Receptors | 1 | 2005 | 3 | 0.030 |
Why?
| | Receptors, Neurotransmitter | 1 | 2005 | 10 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2006 | 139 | 0.030 |
Why?
| | Wnt3 Protein | 1 | 2005 | 7 | 0.030 |
Why?
| | Wnt1 Protein | 1 | 2005 | 10 | 0.030 |
Why?
| | Culture Media, Serum-Free | 1 | 2005 | 14 | 0.030 |
Why?
| | Cycloheximide | 1 | 2005 | 35 | 0.030 |
Why?
| | Wnt3A Protein | 1 | 2005 | 12 | 0.030 |
Why?
| | Green Fluorescent Proteins | 1 | 2005 | 89 | 0.030 |
Why?
| | Culture Media | 1 | 2005 | 98 | 0.030 |
Why?
| | DNA Damage | 1 | 2017 | 307 | 0.030 |
Why?
| | Histones | 1 | 2017 | 316 | 0.030 |
Why?
| | Binding Sites | 1 | 2005 | 379 | 0.030 |
Why?
| | Skull | 1 | 2005 | 80 | 0.030 |
Why?
| | Molecular Structure | 1 | 2005 | 315 | 0.030 |
Why?
| | ets-Domain Protein Elk-1 | 1 | 2003 | 5 | 0.030 |
Why?
| | CCAAT-Enhancer-Binding Protein-alpha | 1 | 2003 | 5 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2014 | 186 | 0.030 |
Why?
| | Diabetes Mellitus | 1 | 2007 | 315 | 0.030 |
Why?
| | Estrogen Antagonists | 1 | 2003 | 21 | 0.030 |
Why?
| | Phosphotransferases | 1 | 2003 | 17 | 0.030 |
Why?
| | Enzyme Inhibitors | 1 | 2005 | 374 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-fos | 1 | 2003 | 60 | 0.030 |
Why?
| | Selective Estrogen Receptor Modulators | 1 | 2003 | 23 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 2003 | 76 | 0.030 |
Why?
| | Atrophy | 1 | 2013 | 48 | 0.030 |
Why?
| | Microtubule-Associated Proteins | 1 | 2013 | 65 | 0.030 |
Why?
| | Cytoplasm | 1 | 2003 | 97 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2014 | 555 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 1 | 2014 | 484 | 0.030 |
Why?
| | Plasmids | 1 | 2003 | 167 | 0.030 |
Why?
| | Uterus | 1 | 2013 | 88 | 0.020 |
Why?
| | Survival Analysis | 1 | 2014 | 671 | 0.020 |
Why?
| | Radiography | 1 | 2013 | 470 | 0.020 |
Why?
| | Down-Regulation | 1 | 2003 | 347 | 0.020 |
Why?
| | Body Composition | 1 | 2014 | 339 | 0.020 |
Why?
| | DNA | 1 | 2005 | 550 | 0.020 |
Why?
| | Body Mass Index | 1 | 2014 | 689 | 0.020 |
Why?
| | Diet | 1 | 2014 | 588 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2003 | 1377 | 0.020 |
Why?
| | Time Factors | 1 | 2005 | 2957 | 0.020 |
Why?
|
|
Schuller De Almeida's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|